These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21512639)

  • 1. French Haemovigilance Data on Platelet Transfusion.
    Willaert B; Vo Mai MP; Caldani C
    Transfus Med Hemother; 2008; 35(2):118-121. PubMed ID: 21512639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative platelet transfusion: recommendations of the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS) 2003.
    Samama CM; Djoudi R; Lecompte T; Nathan-Denizot N; Schved JF;
    Can J Anaesth; 2005 Jan; 52(1):30-7. PubMed ID: 15625253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-RH1 (anti-D) alloimmunization after transfusion of platelet concentrates from RH :1 donors].
    Duboeuf S; Flourié F; Courbil R; Oriol P; Benamara A; Chartier M; Rigal E; Garraud O
    Ann Biol Clin (Paris); 2009; 67(3):353-7. PubMed ID: 19411240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inspection of transfusion sites by the French Blood Establishment].
    Chevrolle F; Hadzlik E; Suchel PL
    Transfus Clin Biol; 2001 Dec; 8(6):485-9. PubMed ID: 11802612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency (AFSSAPS) 2003.
    Samama CM; Djoudi R; Lecompte T; Nathan N; Schved JF;
    Minerva Anestesiol; 2006 Jun; 72(6):447-52. PubMed ID: 16682914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity transfusion reactions to platelet concentrate: a retrospective analysis of the French hemovigilance network.
    Mertes PM; Tacquard C; Andreu G; Kientz D; Gross S; Malard L; Drouet C; Carlier M; Gachet C; Sandid I; Boudjedir K
    Transfusion; 2020 Mar; 60(3):507-512. PubMed ID: 30907010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigilance in industry: cosmetics and household cleaning products. Balance sheet of case report from 2005 to 2007.
    Kornfeld-Lecanu S; Zajaczkowski F; Dubourg S; Martin L; Lefort S; Siest S
    Clin Exp Dermatol; 2010 Dec; 35(8):874-80. PubMed ID: 20718782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013.
    Andreu G; Boudjedir K; Muller JY; Pouchol E; Ozier Y; Fevre G; Gautreau C; Quaranta JF; Drouet C; Rieux C; Mertes PM; Clavier B; Carlier M; Sandid I
    Transfus Med Rev; 2018 Jan; 32(1):16-27. PubMed ID: 28864336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transfusion in haematology].
    Renaudier P
    Transfus Clin Biol; 2008 Nov; 15(5):228-35. PubMed ID: 18930422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From psychoactive medicines to addictovigilance in French Public Health Code (1990-2017)].
    Baumevieille M; Perri-Plandé J; Miremont-Salamé G; Daveluy A; Haramburu F
    Therapie; 2019 Jun; 74(3):375-382. PubMed ID: 30193805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module.
    Mowla SJ; Kracalik IT; Sapiano MRP; O'Hearn L; Andrzejewski C; Basavaraju SV
    Transfus Med Rev; 2021 Apr; 35(2):78-84. PubMed ID: 33934903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).
    Thiessard F; Roux E; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Tubert-Bitter P; Bégaud B
    Drug Saf; 2005; 28(8):731-40. PubMed ID: 16048358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment recommendations for type 2 diabetes. Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)].
    Diabetes Metab; 1999 Dec; 25 Suppl 6():1-79. PubMed ID: 10697746
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transfusion incidents related to bacterial contamination: review of the literature and hemovigilance data. For the working group Bacterial incidents of French Blood Agency, scientific advice of Bacthem and the French hemovigilance network].
    Perez P; Ngombet R; Debeir J; Noël L; Sari F
    Transfus Clin Biol; 1998 Jun; 5(3):203-10. PubMed ID: 9691364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.
    Andreu G; Morel P; Forestier F; Debeir J; Rebibo D; Janvier G; Hervé P
    Transfusion; 2002 Oct; 42(10):1356-64. PubMed ID: 12423521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-ulcer agents: indications in adults. Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)].
    Ann Med Interne (Paris); 2000 Sep; 151(5):353-68. PubMed ID: 11033469
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology of Transfusion Related Acute Lung Injury in France: Preliminary Results.
    Renaudier P; Schlanger S; Vo Mai MP; Ounnoughene N; Breton P; Cheze S; Girard A; Hauser L; Legras JF; Odent-Malaure H; Rebibo D; Waller C; Willaert B; Caldani C;
    Transfus Med Hemother; 2008; 35(2):89-91. PubMed ID: 21512633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data.
    Daurat A; Roger C; Gris J; Daurat G; Feissel M; Le Manach Y; Lefrant J; Muller L
    Transfusion; 2016 Jun; 56(6):1295-303. PubMed ID: 26814984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018.
    Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP
    Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmaceutical development aimed at improving safety for children].
    Andrieu V; Reynier JP
    Therapie; 2004; 59(6):599-601. PubMed ID: 15789821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.